Abstract
Aim: To investigate the anticancer mechanisms of silver nanoparticles (AgNPs) in colorectal cancer. Methods: Anticancer effects of AgNPs were determined in colorectal cancer HCT116 cells and xenograft mice using cellular and molecular methods. Results: AgNPs induced mitochondrial reactive oxygen species production, mitochondrial dysfunction and endoplasmic reticulum (ER) stress responses through NOX4 and led to HCT116 cell apoptosis. Pretreatment with DPI or 4-PBA significantly inhibited mitochondrial reactive oxygen species production, apoptosis, ER stress response, NOX4 expression and mitochondrial dysfunction in AgNP-treated HCT116 cells. AgNPs also significantly suppressed HCT116 cell-based xenograft tumor growth in nude mice by inducing apoptosis and ER stress responses. Conclusion: AgNPs exert anticancer effects against colorectal cancer via ROS- and ER stress-related mitochondrial apoptosis pathways.
Papers of special note have been highlighted as: • of interest; •• of considerable interest
References
- 1. . Silver nanoparticles: biomedical applications, toxicity, and safety issues. Int. J. Pharm. Pharm. Sci. 2(4), 1–10 (2017).
- 2. Biomedical applications of silver nanoparticles: an up-to-date overview. Nanomaterials (Basel) 8(9), 681 (2018).
- 3. . Health impact of silver nanoparticles: a review of the biodistribution and toxicity following various routes of exposure. Int. J. Mol. Sci. 21(7), 2375 (2020).
- 4. Oxidative stress induced antimicrobial efficacy of chitosan and silver nanoparticles coated gutta-percha for endodontic applications. Mater. Today Chem. 17, 100299 (2020).
- 5. . Cancer statistics, 2016. CA Cancer J. Clin. 66(1), 7–30 (2016).
- 6. Silver nanoparticles for enhanced cancer theranostics: in vitro and in vivo perspectives. J. Biomed. Nanotechnol. 14(9), 1515–1542 (2018). •• Reviews the applications of silver nanoparticles (AgNPs) in cancer theranostics in vitro and in vivo as well as the nanotoxicity of AgNPs.
- 7. . Silver nanoparticles: synthetic routes, in vitro toxicity and theranostic applications for cancer disease. Nanomaterials (Basel) 8(5), 319 (2018).
- 8. Silver nanoparticles selectively treat triple-negative breast cancer cells without affecting non-malignant breast epithelial cells in vitro and in vivo. FASEB Bioadv. 1(10), 639–660 (2019). • Provides evidence for reducing the growth of solid mammary tumors in mice by systemic administration of AgNPs.
- 9. Effects of green-synthesized silver nanoparticles on lung cancer cells in vitro and grown as xenograft tumors in vivo. Int. J. Nanomedicine 11, 1879–1887 (2016). • Provides evidence for the antitumor activity of green-synthesized AgNPs against lung cancer in vitro and in vivo.
- 10. . Antitumor activity of silver nanoparticles in Ehrlich carcinoma-bearing mice. Naunyn Schmiedebergs Arch. Pharmacol. 391(12), 1421–1430 (2018).
- 11. Effects of green synthesised silver nanoparticles (ST06-AgNPs) using curcumin derivative (ST06) on human cervical cancer cells (HeLa) in vitro and EAC tumor bearing mice models. Int. J. Nanomedicine 14, 5257–5270 (2019).
- 12. Immunomodulatory properties of silver nanoparticles contribute to anticancer strategy for murine fibrosarcoma. Cell. Mol. Immunol. 13(2), 191–205 (2016).
- 13. Antiproliferative and antitumour effect of nongenotoxic silver nanoparticles on melanoma models. Oxid. Med. Cell Longev. 2019, 4528241 (2019). • Provides evidence for the antiproliferative and antitumour effect of AgNPs in murine melanoma following the recommended protocol by the NIH.
- 14. Activity and pharmacology of homemade silver nanoparticles in refractory metastatic head and neck squamous cell cancer. Head Neck 41(1), 11–16 (2019).
- 15. WHO. WHO report on cancer: setting priorities, investing wisely and providing care for all (2020). https://apps.who.int/iris/handle/10665/330745
- 16. Cytotoxic potential and molecular pathway analysis of silver nanoparticles in human colon cancer cells HCT116. Int. J. Mol. Sci. 19(8), 2269 (2018).
- 17. Evaluation of the genotoxic and oxidative damage potential of silver nanoparticles in human NCM460 and HCT116 cells. Int. J. Mol. Sci. 21(5), 1618 (2020).
- 18. Mechanistic insight into the rapid one-step facile biofabrication of antibacterial silver nanoparticles from bacterial release and their biogenicity and concentration-dependent in vitro cytotoxicity to colon cells. RSC Adv. 7, 40034–40045 (2017).
- 19. Involvement of endoplasmic reticulum stress response and IRE1-mediated ASK1/JNK/Mcl-1 pathways in silver nanoparticle-induced apoptosis of human retinal pigment epithelial cells. Toxicology 442, 152540 (2020).
- 20. Cell death and survival through the endoplasmic reticulum-mitochondrial axis. Curr. Mol. Med. 13(2), 317–329 (2013). •• Reviews the coordination and communication between endoplasmic reticulum (ER) and mitochondria to modulate organelle function and determine cellular fate.
- 21. . BCL-2 family: integrating stress responses at the ER to control cell demise. Cell. Death. Differ. 24, 1478–1487 (2017).
- 22. Endoplasmic reticulum stress provocation by different nanoparticles: an innovative approach to manage the cancer and other common diseases. Molecules 25(22), 5336 (2020).
- 23. . Apoptosis signal-regulating kinase 1 (ASK1) activation is involved in silver nanoparticles induced apoptosis of A549 lung cancer cell line. J. Biomed. Nanotechnol. 13(3), 349–54 (2017).
- 24. . Reactive oxygen species and mitochondria: a nexus of cellular homeostasis. Redox Biol. 6, 472–485 (2015).
- 25. Silver nanoparticle-induced apoptosis in ARPE-19 cells is inhibited by Toxoplasma gondii pre-infection through suppression of NOX4-dependent ROS generation. Int. J. Nanomedicine 15, 3695–3716 (2020).
- 26. NOX4- and Nrf2-mediated oxidative stress induced by silver nanoparticles in vascular endothelial cells. J. Appl. Toxicol. 37(12), 1428–1437 (2017).
- 27. . Mitochondria – judges and executioners of cell death sentences. Mol. Cell. 61, 695–704 (2016). •• Reviews the structure and role of mitochondria in apoptosis induction and mechanism of action of apoptotic signaling pathways.
- 28. Silica nanoparticles induce mitochondrial pathway-dependent apoptosis by activating unfolded protein response in human neuroblastoma cells. Environ. Toxicol. 36(4), 675–685 (2021).
- 29. Silica nanoparticles induced endothelial apoptosis via endoplasmic reticulum stress–mitochondrial apoptotic signaling pathway. Chemosphere 210, 183–192 (2018). • Study on the coordination and communication between ER and mitochondria to modulate organelle function and determine cellular fate.
- 30. Endoplasmic reticulum stress cooperates in silica nanoparticles-induced macrophage apoptosis via activation of CHOP-mediated apoptotic signaling pathway. Int. J. Mol. Sci. 20, 5846 (2019).
- 31. Bcl-2 family proteins are involved in the signal crosstalk between endoplasmic reticulum stress and mitochondrial dysfunction in tumor chemotherapy resistance. Biomed. Res. Int. 2014, 234370 (2014).
- 32. . Silver nanoparticles induce irremediable endoplasmic reticulum stress leading to unfolded protein response dependent apoptosis in breast cancer cells. Apoptosis 21(11), 1279–1290 (2016).
- 33. Comparisons of the biodistribution and toxicological examinations after repeated intravenous administration of silver and gold nanoparticles in mice. Sci. Rep. 7(1), 3303 (2017).
- 34. Silver nanoparticles: synthesis, medical applications and biosafety. Theranostics 10(20), 8996–9031 (2020).
- 35. . Bactericidal and cytotoxic properties of silver nanoparticles. Int. J. Mol. Sci. 20(2), 449 (2019).